- Home
- RFIL vs FBRX Comparison
RFIL vs FBRX Comparison
Compare RFIL & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFIL
- FBRX
- Stock Information
- Founded
- RFIL 1979
- FBRX N/A
- Country
- RFIL United States
- FBRX United States
- Employees
- RFIL N/A
- FBRX N/A
- Industry
- RFIL Electrical Products
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- RFIL Technology
- FBRX Health Care
- Exchange
- RFIL Nasdaq
- FBRX Nasdaq
- Market Cap
- RFIL 39.9M
- FBRX 44.8M
- IPO Year
- RFIL N/A
- FBRX N/A
- Fundamental
- Price
- RFIL $4.11
- FBRX $9.55
- Analyst Decision
- RFIL Strong Buy
- FBRX Strong Buy
- Analyst Count
- RFIL 1
- FBRX 3
- Target Price
- RFIL $4.50
- FBRX $80.50
- AVG Volume (30 Days)
- RFIL 29.9K
- FBRX 65.9K
- Earning Date
- RFIL 06-12-2025
- FBRX 05-15-2025
- Dividend Yield
- RFIL N/A
- FBRX N/A
- EPS Growth
- RFIL N/A
- FBRX N/A
- EPS
- RFIL N/A
- FBRX N/A
- Revenue
- RFIL $70,599,000.00
- FBRX N/A
- Revenue This Year
- RFIL $16.16
- FBRX N/A
- Revenue Next Year
- RFIL $5.75
- FBRX N/A
- P/E Ratio
- RFIL N/A
- FBRX N/A
- Revenue Growth
- RFIL 4.93
- FBRX N/A
- 52 Week Low
- RFIL $3.15
- FBRX $4.11
- 52 Week High
- RFIL $5.77
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- RFIL 48.57
- FBRX 59.42
- Support Level
- RFIL $4.22
- FBRX $7.78
- Resistance Level
- RFIL $4.43
- FBRX $13.84
- Average True Range (ATR)
- RFIL 0.16
- FBRX 1.41
- MACD
- RFIL 0.01
- FBRX 0.15
- Stochastic Oscillator
- RFIL 39.09
- FBRX 39.92
About RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. The company has operations in the United States, Canada, Israel, and Mexico.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).